Repetitive transkranielle Magnetstimulation (rTMS) bei Angsterkrankungen – eine mögliche Therapieoption?

N. Vennewald; J. Diemer; P. Zwanzger

doi:10.1055/s-0033-1335979

Fortschritte der Neurologie · Psychiatrie, Table of Contents

Fortschr Neurol Psychiatr 2013; 81(10): 550-560
DOI: 10.1055/s-0033-1335979

Übersicht

Repetitive transkranielle Magnetstimulation (rTMS) bei Angsterkrankungen – eine mögliche Therapieoption?

Eine systematische ÜbersichtRepetitive Transcranial Magnetic Stimulation (rTMS) for Anxiety Disorders – A Possible Therapeutic Option? A Systematic Review

N. Vennewald

¹Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universität Münster

,

J. Diemer

²Lehrstuhl für Klinische Psychologie und Psychotherapie, Universität Regensburg

,

P. Zwanzger

¹Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universität Münster

› Author Affiliations

Abstract

Zusammenfassung

Angsterkrankungen zählen zu den häufigsten psychischen Störungen. Obgleich für die Therapie sowohl wirksame psychotherapeutische als auch psychopharmakologische Behandlungsansätze existieren, spricht ein Teil der Patienten nicht oder nur unzureichend auf die Therapie an. Die repetitive transkranielle Magnetstimulation (rTMS) moduliert kortikale Aktivität lokal, ist nicht invasiv und wird als potenziell neues Therapieverfahren bei psychischen Störungen diskutiert. Diese Arbeit gibt einen systematischen Überblick über Fallberichte, offene sowie randomisiert-kontrollierte Studien zur therapeutischen Anwendung der rTMS bei Angsterkrankungen. Zusammengefasst könnte die rTMS eine mögliche therapeutische Alternative zu konventionellen Verfahren darstellen. Gleichwohl sind umfassendere randomisiert-kontrollierte Studien notwendig, um validere Aussagen über die Wirksamkeit der rTMS bei Angsterkrankungen treffen zu können.

Abstract

Anxiety disorders rank among the most frequent psychiatric disorders. Effective psychotherapeutic and psychopharmacological interventions exist, although a considerable number of patients does not respond to standard interventions. Repetitive transcranial magnetic stimulation (rTMS) is capable of modulating cortical activity locally and non-invasively. Therefore, rTMS is discussed as a possible alternative treatment approach in psychiatric disorders. The present paper aims to provide a systematic review of randomised controlled studies, open studies, and case reports examining the potential therapeutic effects of rTMS in anxiety disorders. Overall, these studies suggest beneficial effects of rTMS on anxiety symptoms. Nevertheless, larger randomised controlled studies are warranted to allow a more comprehensive evaluation of the therapeutic efficacy of rTMS in anxiety disorders.

Schlüsselwörter

repetitive transkranielle Magnetstimulation - rTMS - Angsterkrankungen - Panikstörung - PTBS

Key words

repetitive transcranial magnetic stimulation - rTMS - anxiety disorders - panic disorder - PTSD

Full Text

References

Literatur

1 Greenberg PE, Sisitsky T, Kessler RC et al. The economic burden of anxiety disorders in the 1990s. J Clin Psychiatry 1999; 60 (07) 427-435
2 Kessler RC, Berglund P, Demler O et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 2005; 62: 593-602
3 Pallanti S, Bernardi S. Neurobiology of repeated Transcranial Magnetic Stimulation in the treatment of anxiety: a critical review. Int Clin Psychopharmacol 2009; 24: 163-173
4 Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. Am J Psychiatry 2000; 157: 669-682
5 Stein MB, Roy-Byrne PP, Craske MG et al. Functional impact and health utility of anxiety disorders in primary care outpatients. Med Care 2005; 43: 1164-1170
6 Kessler RC, McGonagle KA, Zhao S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51 (01) 8-19
7 Byers AL, Yaffe K, Covinsky KE et al. High occurrence of mood and anxiety disorders among older adults: the National Comorbidity Survey replication. Arch Gen Psychiatry 2010; 67 (05) 489-496
8 Gustavsson A, Svensson M, Jacobi F et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21 (10) 718-779
9 Dengler W, Selbmann HK (Hrsg.). Praxisleitlinien in Psychiatrie und Psychotherapie. Bd. 2 Leitlinien zur Diagnostik und Therapie von Angsterkrankungen. 1. Aufl. Darmstadt: Steinkopff; 2001
10 Bandelow B, Zohar J, Hollander E et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revision. World J Biol Psychiatry 2008; 9 (04) 248-312
11 Hofmann SG, Smits JA. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry 2008; 69 (04) 621-632
12 James A, Soler A, Weatherall R. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev 2005; 4: CD004690
13 Bundespsychotherapeutenkammer. BPtK-Studie zu Wartezeiten in der ambulanten psychotherapeutischen Versorgung: Umfrage der Landespsychotherapeutenkammern und der BPtK. Berlin: 2011
14 Taylor S, Abramowitz JS, McKay D. Non-adherence and non-response in the treatment of anxiety disorders. J Anxiety Disord 2012; 26 (05) 583-589
15 Bandelow B, Rüther E. Treatment-resistant panic disorder. CNS Spectr 2004; 9 (10) 725-739
16 Heilman KM, Gilmore RL. Cortical influences in emotion. J Clin Neurophysiol 2008; 15 (05) 409-423
17 Davis M. The role of the amygdala in fear and anxiety. Annu Rev Neurosci 1992; 15: 353-375
18 Davis M, Walker DL, Miles L et al. Phasic vs sustained fear in rats and humans: Role of the extended amygdala in fear vs anxiety. Neuropsychopharmacol 2010; 35: 105-135
19 Davis M. The role of the amygdala in conditioned and unconditioned fear and anxiety. In: Aggleton JP, (ed.) The Amygdala: a functional analysis. Oxford: Oxford University; 2000: 213-253
20 Charney DS. Neuroanatomical circuits modulating fear and anxiety behaviours. Acta Psychiatr Scand 2003; 417: 38-50
21 Etkin A, Wager TD. Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry 2007; 164: 1476-1488
22 Hariri AR, Mattay VS, Tessitore A et al. Neocortical modulation of the amygdala response to fearful stimuli. Biol Psychiatry 2003; 53: 494-501
23 Hariri AR, Bookheimer SY, Mazziotta JC. Modulating emotional responses: effects of a neocortical network on the limbic system. NeuroReport 2000; 11: 43-48
24 Taylor SF, Phan KL, Decker LR et al. Subjective rating of emotionally salient stimuli modulates neural activity. NeuroImage 2003; 18: 650-659
25 Dresler T, Ehlis AC, Plichta MM et al. Panic disorder and a possible treatment approach by means of high-frequency rTMS: a case report. World J Biol Psychiatry 2009; 10: 991-997
26 Domschke K, Braun M, Ohrmann P et al. Association of the functional 1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol 2006; 9: 349-355
27 Boshuisen ML, Ter HGJ, Paans AMJ et al. rCBF differences between panic disorder patients and control subjects during anticipatory anxiety and rest. Biol Psychiatry 2002; 52: 126-135
28 DeRubeis RJ, Siegle GJ, Hollon SD. Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat Rev Neurosci 2008; 9: 788-796
29 Reuter-Lorenz PA, Davidson RJ. Differential contributions of the two cerebral hemispheres to the perception of happy and sad faces. Neuropsychologia 1981; 19: 609-613
30 Wedding D, Stalans L. Hemispheric differences in the perception of positive and negative faces. Int J Neuroscience 1985; 27: 277-281
31 Schutter DJ, de Weijer AD, Meuwese JD et al. Interrelations between motivational stance, cortical excitability, and the frontal electroencephalogram asymmetry of emotion: a transcranial magnetic stimulation study. Hum Brain Mapp 2008; 29 (05) 574-580
32 Balconi M, Mazza G. Lateralisation effect in comprehension of emotional facial expression: a comparison between EEG alpha band power and behavioural inhibition (BIS) and activation (BAS) systems. Laterality 2010; 15 (03) 361-384
33 Wiedemann G, Pauli P, Dengler W et al. Frontal brain asymmetry as a biological substrate of emotions in patients with panic disorders. Arch Gen Psychiatry 1999; 56: 78-84
34 Rauch SL, Savage CR, Alpert NM et al. The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry 1997; 42 (06) 446-452
35 Lang N, Siebner HR. Repetitive Transkranielle Magnetstimulation. In: Siebner HR, Ziemann U, , (Hrsg.) Das TMS-Handbuch – Handbuch der Transkraniellen Magnetstimulation. 1. Aufl. Heidelberg: Springer; 2007: 500-509
36 Siebner HR, Ziemann U. Hirnstimulation – Physiologische Grundlagen. In: Siebner HR, Ziemann U, , (Hrsg.) Das TMS-Handbuch – Handbuch der Transkraniellen Magnetstimulation. 1. Aufl. Heidelberg: Springer; 2007: 28-44
37 Kanno M, Matsumoto M, Togashi H et al. Effects of repetitive Transcranial Magnetic Stimulation on behavioral and neurochemical changes in rats during an elevated plus-maze test. J Neurol Sci 2003; 211: 5-14
38 Keck ME, Engelmann M, Müller MB et al. Repetitive Transcranial Magnetic Stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats. J Psychiatr Res 2000; 34 (04) 265-276
39 Keck ME, Welt T, Post A et al. Neuroendocrine and behavioral effects of repetitive Transcranial Magnetic Stimulation in a psychopathological animal model are suggestive of antidepressant-like effects. Neuropsychopharmacol 2001; 24: 337-349
40 Hedges DW, Higginbotham BJ, Salyer DL et al. Transcranial Magnetic Stimulation effects on one-trial learning and response to anxiogenic stimuli in adult male rats. J ECT 2005; 21 (01) 25-30
41 Lisanby SH, Belmaker RH. Animal models of the mechanisms of action of repetitive Transcranial Magnetic Stimulation (rTMS): comparisons with electroconvulsive shock (ECS). Depress Anxiety 2000; 12 (03) 178-187
42 Keck ME, Welt T, Müller MB et al. Repetitive Transcranial Magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacol 2002; 43 (01) 101-109
43 Huang YZ, Edwards MJ, Rounis E et al. Theta Burst Stimulation of the human motor cortex. Neuron 2005; 45 (02) 201-206
44 Cárdenas-Morales L, Grön G, Kammer T et al. Exploring the after-effects of Theta Burst Magnetic Stimulation on the human motor cortex: a functional imaging study. Hum Brain Mapp 2011; 32 (11) 1948-1960
45 van Honk J, Schutter DJ, d'Alfonso AA et al. 1 hz rTMS over the right prefrontal cortex reduces vigilant attention to unmasked but not to masked fearful faces. Biol Psychiatry 2002; 52 (04) 312-317
46 Baeken C, De Raedt R, Van Schuerbeek P et al. Right prefrontal HF-rTMS attenuates right amygdala processing of negatively valenced emotional stimuli in healthy females. Behav Brain Res 2010; 214 (02) 450-455
47 Rumi DO, Gattaz WF, Rigonatti SP et al. Transcranial Magnetic Stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biol Psychiatry 2005; 57 (02) 162-166
48 Herwig U, Fallgatter AJ, Höppner J et al. Antidepressant effects of augmentative Transcranial Magnetic Stimulation: randomised multicentre trial. Br J Psychiatry 2007; 191: 441-448
49 Jaafari N, Rachid F, Rotge JY et al. Safety and efficacy of repetitive Transcranial Magnetic Stimulation in the treatment of obsessive-compulsive disorder: a review. World J Biol Psychiatry 2012; 13 (03) 164-177
50 Speer AM, Kimbrell TA, Wassermann EM et al. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients. Biol Psychiatry 2000; 48 (12) 1133-1141
51 Michael N, Gösling M, Reutemann M et al. Metabolic changes after repetitive Transcranial Magnetic Stimulation (rTMS) of the left prefrontal cortex: a sham-controlled proton magnetic resonance spectroscopy (1H MRS) study of healthy brain. Eur J Neurosci 2003; 17 (11) 2462-2468
52 George MS, Wassermann EM, Post RM. Transcranial Magnetic Stimulation: a neuropsychiatric tool for the 21st century. J Neuropsychiatry Clin Neurosci 1996; 8 (04) 373-382
53 O’Reardon JP, Solvason HB, Janicak PG et al. Efficacy and safety of Transcranial Magnetic Stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007; 62 (11) 1208-1216
54 Schlaepfer TE, Kosel M, Nemeroff CB. Efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of affective disorders. Neuropsychopharmacology 2003; 28 (02) 201-205
55 Padberg F, Zwanzger P, Thoma H et al. Repetitive Transcranial Magnetic Stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS. Psychiatry Res 1999; 88 (03) 163-171
56 Pascual-Leone A, Rubio B, Pallardó F et al. Rapid-rate Transcranial Magnetic Stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 1996; 348 (9022) 233-237
57 Koenigs M, Grafman J. The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav Brain Res 2009; 201: 239-243
58 Daskalakis ZJ, Levinson AJ, Fitzgerald PB. Repetitive Transcranial Magnetic Stimulation for major depressive disorder: a review. Can J Psychiatry 2008; 53 (09) 555-566
59 Grossheinrich N, Rau A, Pogarell O et al. Theta Burst Stimulation of the prefrontal cortex: safety and impact on cognition, mood, and resting electroencephalogram. Biol Psychiatry 2009; 65 (09) 778-784
60 Rossi S, Hallett M, Rossini PM et al. Safety, ethical considerations, and application guidelines for the use of Transcranial Magnetic Stimulation in clinical practice and research. Clin Neurophysiol 2009; 120 (12) 2008-2039
61 Machii K, Cohen D, Ramos-Estebanez C et al. Safety of rTMS to non-motor cortical areas in healthy participants and patients. Clin Neurophysiol 2006; 117 (02) 455-471
62 Zwanzger P, Fallgatter AJ, Zavorotnyy M et al. Anxiolytic effects of Transcranial Magnetic Stimulation – an alternative treatment option in anxiety disorders?. J Neural Transm 2009; 116 (06) 767-775
63 Diemer J, Vennewald N, Domschke K et al. Therapy-refractory panic: current research areas as possible perspectives in the treatment of anxiety. Eur Arch Psychiatry Clin Neurosci 2010; 260 (Suppl. 02) S127-S131
64 Phillips KA, Stein DJ, Rauch SL et al. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?. Depress Anxiety 2010; 27 (06) 528-555
65 Hollander E, Braun A, Simeon D. Should OCD leave the anxiety disorders in DSM-V? The case for obsessive compulsive-related disorders. Depress Anxiety 2008; 25 (04) 317-329
66 Berkowitz RL, Coplan JD, Reddy DP et al. The human dimension: how the prefrontal cortex modulates the subcortical fear response. Rev Neurosci 2007; 18 (03) 191-207
67 Sleith C. The Scottish Intercollegiate Guidelines Network (SIGN): Methodology Checklist 2: Controlled Trial. . Zugriff am 18.03.2013 von http://www.sign.ac.uk/methodology/checklists.html
68 Guaiana G, Mortimer AM, Robertson C. Efficacy of Transcranial Magnetic Stimulation in panic disorder: a case report. Aust N Z J Psychiatry 2005; 39 (11) 1047
69 Zwanzger P, Minov C, Ella R et al. Transcranial Magnetic Stimulation for panic. Am J Psychiatry 2002; 159 (02) 315-316
70 Mantovani A, Lisanby SH, Pieraccini F et al. Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression. J Affect Disord 2007; 102 (01) 277-280
71 Prasko J, Záleský R, Bares M et al. The effect of repetitive Transcranial Magnetic Stimulation (rTMS) add on serotonin reuptake inhibitors in patients with panic disorder: a randomized, double blind sham controlled study. Neuro Endocrinol Lett 2007; 28 (01) 33-38
72 Mantovani A, Aly M, Dagan Y et al. Randomized sham controlled Transcranial Magnetic Stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid depression. J Affect Disorders 2013; 144 (01) 153-159
73 Bystritsky A, Kaplan JT, Feusner JD et al. A preliminary study of fMRI-guided rTMS in the treatment of generalized anxiety disorder. J Clin Psychiatry 2008; 69 (07) 1092-1098
74 Bystritsky A, Kerwin LE, Feusner JD. A preliminary study of fMRI-guided rTMS in the treatment of generalized anxiety disorder: 6-month follow up. J Clin Psychiatry 2009; 70 (03) 431-432
75 De Bellis MD, Casey BJ, Dahl RE et al. A pilot study of amygdala volumes in pediatric generalized anxiety disorder. Biol Psychiatry 2000; 48 (01) 51-57
76 Etkin A, Prater KE, Schatzberg AF et al. Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder. Arch Gen Psychiatry 2009; 66 (12) 1361-1372
77 Schienle A, Ebner F, Schäfer A. Localized gray matter volume abnormalities in generalized anxiety disorder. Eur Arch Psychiatry Clin Neurosci 2011; 261 (04) 303-307
78 Monk CS, Telzer EH, Mogg K et al. Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Arch Gen Psychiatry 2008; 65 (05) 568-576
79 McCann UD, Kimbrell TA, Morgan CM et al. Repetitive Transcranial Magnetic Stimulation for posttraumatic stress disorder. Arch Gen Psychiatry 1998; 55 (03) 276-279
80 Grisaru N, Amir M, Cohen H et al. Effect of Transcranial Magnetic Stimulation in posttraumatic stress disorder: a preliminary study. Biol Psychiatry 1998; 44 (01) 52-55
81 Rosenberg PB, Mehndiratta RB, Mehndiratta YP et al. Repetitive Transcranial Magnetic Stimulation treatment of comorbid posttraumatic stress disorder and major depression. J Neuropsychiatry Clin Neurosci 2002; 14 (03) 270-276
82 Cohen H, Kaplan Z, Kotler M et al. Repetitive Transcranial Magnetic Stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study. Am J Psychiatry 2004; 161 (03) 515-524
83 Osuch EA, Benson BE, Luckenbaugh DA et al. Repetitive TMS combined with exposure therapy for PTSD: a preliminary study. J Anxiety Disord 2009; 23 (01) 54-59
84 Boggio PS, Rocha M, Oliveira MO et al. Noninvasive brain stimulation with high-frequency and low-intensity repetitive Transcranial Magnetic Stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry 2010; 71 (08) 992-999
85 Watts BV, Landon B, Groft A et al. A sham controlled study of repetitive Transcranial Magnetic Stimulation for posttraumatic stress disorder. Brain Stimul 2012; 5 (01) 38-43
86 Couturier JF. Efficacy of rapid-rate repetitive Transcranial Magnetic Stimulation in the treatment of depression: a systematic review and meta-analysis. J Psychiatry Neurosci 2005; 30 (02) 83-90
87 Galletly C, Gill S, Clarke P et al. A randomized trial comparing repetitive Transcranial Magnetic Stimulation given 3 days/week and 5 days/week for the treatment of major depression: is efficacy related to the duration of treatment or the number of treatments?. Psychol Med 2012; 42 (05) 981-988
88 Padberg F, Zwanzger P, Keck M et al. Repetitive Transcranial Magnetic Stimulation (rTMS) in major depression: relation between efficacy and stimulation intensity. Neuropsychopharmacol 2002; 27 (04) 638-645
89 Cheeran B, Talelli P, Mori F et al. A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol 2008; 586: 5717-5725
90 Pell GS, Roth Y, Zangen A. Modulation of cortical excitability induced by repetitive transcranial magnetic stimulation: influence of timing and geometrical parameters and underlying mechanisms. Prog Neurobiol 2011; 93 (01) 59-98
91 Siebner HR, Hartwigsen G, Kassuba T et al. How does Transcranial Magnetic Stimulation modify neuronal activity in the brain?. Implications for studies of cognition. Cortex 2009; 45 (09) 1035-1042
92 Roth Y, Amir A, Levkovitz Y et al. Three-dimensional distribution of the electric field induced in the brain by Transcranial Magnetic Stimulation using figure-8 and deep H-coils. J Clin Neurophysiol 2007; 24 (01) 31-38
93 Zangen A, Roth Y, Voller B et al. Transcranial Magnetic Stimulation of deep brain regions: evidence for efficacy of the H-coil. Clin Neurophysiol 2005; 116 (04) 775-779
94 Levkovitz Y, Roth Y, Harel EV et al. A randomized controlled feasibility and safety study of deep Transcranial Magnetic Stimulation. Clin Neurophysiol 2007; 118 (12) 2730-2744
95 Harel EV, Rabany L, Deutsch L et al. H-coil repetitive Transcranial Magnetic Stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study. World J Biol Psychiatry [Epub ahead of print]
96 Levkovitz Y, Sheer A, Harel EV et al. Differential effects of deep TMS of the prefrontal cortex on apathy and depression. Brain Stimul 2011; 4 (04) 266-274
97 Lisanby SH, Gutman D, Luber B et al. Sham TMS: intracerebral measurement of the induced electrical field and the induction of motor-evoked potentials. Biol Psychiatry 2001; 49 (05) 460-463
98 Rossi S, Ferro M, Cincotta M et al. A real electro-magnetic placebo (REMP) device for sham Transcranial Magnetic Stimulation (TMS). Clin Neurophysiol 2007; 118 (03) 709-716